APA (7th ed.) Citation

Tanaka, M., Terry, R., Koyanagi, T., Inagaki, K., Kofidis, T., Mochly-Rosen, D., & Robbins, R. (2004). Combined treatment with epsilon protein kinase C activator and delta protein kinase C inhibitor ameliorates ischemia reperfusion injury and graft coronary artery disease in murine cardiac allografts. Journal of Heart & Lung Transplantation, 23, S126. https://doi.org/10.1016/j.healun.2003.11.249

Chicago Style (17th ed.) Citation

Tanaka, M., R.D Terry, T. Koyanagi, K. Inagaki, T. Kofidis, D. Mochly-Rosen, and R.C Robbins. "Combined Treatment with Epsilon Protein Kinase C Activator and Delta Protein Kinase C Inhibitor Ameliorates Ischemia Reperfusion Injury and Graft Coronary Artery Disease in Murine Cardiac Allografts." Journal of Heart & Lung Transplantation 23 (2004): S126. https://doi.org/10.1016/j.healun.2003.11.249.

MLA (9th ed.) Citation

Tanaka, M., et al. "Combined Treatment with Epsilon Protein Kinase C Activator and Delta Protein Kinase C Inhibitor Ameliorates Ischemia Reperfusion Injury and Graft Coronary Artery Disease in Murine Cardiac Allografts." Journal of Heart & Lung Transplantation, vol. 23, 2004, p. S126, https://doi.org/10.1016/j.healun.2003.11.249.